PHAXIAM Therapeutics SA ADR (PHXM) Debt to Equity (2012 - 2023)
PHAXIAM Therapeutics SA ADR (PHXM) debt to equity from Dec 31, 2012 to Dec 31, 2023. The current PHAXIAM Therapeutics SA ADR (PHXM) debt to equity is 42.64%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Debt to Equity
Debt to Equity
Annual Debt to Equity change of PHAXIAM Therapeutics SA ADR (PHXM)
| Year | Debt to Equity | Change |
|---|---|---|
| 2023 | 42.64% | -26.19% |
| 2022 | 57.77% | -47.99% |
| 2021 | 111.07% | +7.39% |
| 2020 | 103.43% | +526.73% |
| 2019 | 16.50% | +1089.53% |
| 2018 | 1.39% | -11.69% |
| 2017 | 1.57% | -80.49% |
| 2016 | 8.05% | +434.54% |
| 2015 | 1.51% | -29.92% |
| 2014 | 2.15% | -71.08% |
| 2013 | 7.43% | -102.72% |
| 2012 | -273.70% | +20.73% |
| 2011 | -226.70% | -4622.70% |
| 2010 | 5.01% | N/A |
Comparison PHAXIAM Therapeutics SA ADR (PHXM) debt to equity with competitors
PHAXIAM Therapeutics SA ADR (PHXM) debt to equity is 42.64%.